Background: Clock genes play a role in adipose tissue (AT) in animal experimental models. However, it remains to be elucidated whether these genes are expressed in human AT. Objective: We investigated the expression of several clock genes, Bmal1, Per2 and Cry1, in human AT from visceral and subcutaneous abdominal depots. A second objective was to elucidate whether these clock genes expressions were related to the metabolic syndrome features. Methods: Visceral and subcutaneous AT samples were obtained from morbid obese men (n ¼ 8), age: 42713 years and body mass indexX40 kg/m 2 , undergoing laparoscopic surgery due to obesity. Biopsies were taken as paired samples at the beginning of the surgical process (1100 hour). Metabolic syndrome features such as waist circumference, plasma glucose, triglycerides, total cholesterol, high-density lipoprotein cholesterol and low-density lipoprotein (LDL) cholesterol were also studied. Homeostasis model assessment index of insulin resistance was also calculated. The expression of the different clock genes, hBmal1, hPer2 and hCry1, was determined by quantitative real-time PCR. Results: Clock genes were expressed in both human AT depots. hBmal1 expression was significantly lower than hPer2 and hCry1 in both AT (Po0.001). All genes were highly correlated to one another in the subcutaneous fat, while no correlation was found between Bmal1 and Per2 in the visceral AT. Clock genes AT expression was associated with the metabolic syndrome parameters: hPer2 expression level from visceral depot was inversely correlated to waist circumference (Po0.01), while the three clock genes studied were significantly and negatively correlated to total cholesterol and LDL cholesterol (Po0.01). Conclusion: We have demonstrated for the first time in humans that clock genes are expressed in both subcutaneous and visceral fat. Their association with abdominal fat content and cardiovascular risk factors may be an indicator of the potential role of these clock genes in the metabolic syndrome disturbances.
Introduction
Major components of energy homeostasis, including the sleep-wake cycle, thermogenesis, feeding, and glucose and lipid metabolism, are subjected to circadian regulation that synchronizes energy intake and expenditure with changes in the external environment imposed by the rising and setting of the sun. [1] [2] [3] In mammals, a master clock generating circadian rhythms is located in the suprachiasmatic nucleus (SCN) of the hypothalamus, 4 ,5 which orchestrates 24-h cycles in these behavioral and physiological rhythms.
In its simplest form, the molecular clock work consists of autoregulatory transcriptional and translational feedback loops that have both positive and negative elements. 6 On the one hand, CLOCK and BMAL1, the positive components, are two basic helix-loop-helix, Per-Arnt-Sim domaincontaining transcription factors; on the other hand, PER and CRY appear as negative components of the feedback loop. CLOCK heterodimerizes with BMAL1 to drive the rhythmic expression of mPer and mCry. 7, 8 After accumulating in the cytoplasm, PER and CRY proteins heterodimerize and translocate toward the nucleus, where they regulate the activity of CLOCK:BMAL1, completing a transcriptional/ translational feedback loop. 9, 10 Therefore, the peak expression of these two distinct sets of genes occurs in the SCN in antiphase with respect to each other. The intracellular circadian clock system resides not only in the hipothalamic suprachiasmatic nucleous, which is recognized as being the mammalian central clock, but also in various peripheral tissues. [11] [12] [13] Indeed, it has been demonstrated that the suprachiasmatic nucleous is not essential for driving peripheral oscillations but rather acts as a synchronizer of peripheral oscillators. 13 Therefore, the physiological rythmicity in peripheral tissues may be controlled directly by their own clock genes. In adipose tissue (AT), certain clock genes have been shown to regulate the expression of some adipocytokines in a rythmic-dependent manner, at least at the mRNA level. In fact, most bioactive substances, such as adiponectin, resistin and leptin, show a 24-h rhythmicity. Moreover, it has been recently demonstrated in mice that clock genes play a role in AT and that their expression in this tissue exhibits rythmicity in experimental models.
AT function in several disease states is associated with altered circadian rhythms. Recently, two studies performed in mice have proved relationships between circadian mechanism dysfunctions and metabolic abnormalities. In this respect, Ando et al.
14 have observed that the rhythmic expression of clock genes was mildly attenuated in obese KK mice (a model of light or minor obesity) and greatly attenuated in more obese, diabetic KK-A y mice (a model of severe obesity and diabetes). This idea is reinforced in the study of Turek et al., 15 who found that homozygous Clock mutant knockout mice have a greatly attenuated diurnal feeding rhythmicity, are hyperphagic and obese, and develop metabolic syndrome characterized by hyperleptinemia, hyperlipidemia, hepatic steatosis, hyperglycemia and hypoinsulinemia. For this reason, obesity leading to insulin resistance and type 2 diabetes dampens the regulation of the clock genes. However, it remains to be elucidated whether clock genes are expressed in human AT, and if the relative expression level at a certain hour of the day is similar to that found in previous experimental studies. In addition, it would be of interest to compare the clock genes expression levels in visceral and subcutaneous fat depots/or whether the clock genes are related with the metabolic syndrome features. To address these issues, we investigated the mRNA level of several clock genes in human AT derived from subcutaneous and visceral adipose depots, and also examined if this expression was correlated with different metabolic syndrome features.
Subjects and methods

Subjects
Visceral and subcutaneous abdominal AT biopsies were obtained from a total of eight men (mean age 42713 years) with morbid obesity (body mass index (BMI)X40 kg/m 2 ), undergoing laparoscopic gastric by-pass surgery due to obesity and after an overnight fast. Interventions were performed in the General Surgery Service of 'Virgen de la Arrixaca' University Hospital. AT biopsies were taken as paired samples from the two AT depots at the beginning of the surgical procedure (between 1100 and 1200 hours). Visceral AT was taken from the omental depot. The abdominal subcutaneous AT was taken 5 cm lateral from umbilicus. All biopsies were immediately frozen at À801C.
Protocols were approved by the Ethics Committee of the 'Virgen de la Arrixaca' University Hospital, and all participants signed a written informed consent before biopsies were obtained.
Anthropometric measurements
The evaluation of obesity was carried out according to the criteria proposed by the Spanish Society for the Study of Obesity in 2007. 16 Weight was determined in subjects wearing light clothes and bare-footed, using a digital electronic weighing scale. Height was determined using a Harpenden digital stadiometer (range 0.70-2.05 m), with the subject upright and the head in the Frankfurt plane. From these data, BMI was calculated. Total body fat (%) was measured by bioimpedance with a TANITA Model TBF-300 (TANITA Corporation of America, Arlington Heights, IL, USA).
Metabolic syndrome features
Body fat distribution was assessed using the waist circumference, midway between the lower rib margin and the iliac crest, and hip circumference, the widest girth over the great trocanters.
Fasting blood samples were collected the day before surgery. Plasma and serum samples were obtained by centrifugation and stored at À801C until analyzed. Glucose was determined in serum, whereas the other determinations were all carried out in plasma.
Serum glucose concentration was measured in duplicate by the glucose oxidase method. Insulin was determinate by IRMA reagents from Biosource (Fleurus, Belgium). The sensitivity of the method was 1 mIU/ml. The intra-assay coefficient of variation was 4.5% at a serum insulin concentration of 6.6 mIU/ml and 2.1% at 53 mIU/ml. C-peptid was obtained by RIA reagents with a kit commercial CPeptide-Coat from Byk-Sangtec Diagnostica (von HevesyStrasse, Dietzenbag, Germany). The assays had sensitivities of 0.3-2.5 ng/ml.
The homeostasis model assessment (HOMA) index of insulin resistance was calculated with the accepted formula:
HOMA ¼ fasting glucose (mmol/l) Â fasting insulin (mIU/l)/ 22.5.
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Plasma concentrations of triacylglycerols, total cholesterol, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterols were determined with commercial kits (Roche Diagnostics GmbH, Mannheim, Germany). Arterial pressure was measured with a mercury sphygmomanometer.
Clock genes and metabolic syndrome in humans P Gómez-Abellán et al RNA extraction from AT Total RNA was extracted from AT samples using Trizol Reagent (Invitrogen, Paisley, UK) according to the instructions of the manufacturer. The lipid fraction was previously removed with a chloroform solution. RNA was quantified by measuring absorbance at 260 and 280 nm. The integrity of the RNA was checked by 1% agarose gel electrophoresis of the two ribosomal RNAs 18S and 28S.
Real-time PCR measurement of clock genes mRNA Reverse transcription was performed using random hexamers as primers and Thermoscript reverse transcriptase (Invitrogen, Cergy Pontoise, France) from 3 mg total RNA for each sample.
Quantitative real-time PCR was performed using an ABI PRISM 7900 HT Sequence Detection System as described by the provider (Applied Biosystems, Foster City, CA, USA). PCR Master MIX (Perkin-Elmer, Norwalk, CT, USA) containing Hot Start Taq DNA polymerase was used. Taqman probes for human clock genes and 18S rRNA as internal control were also supplied by Applied Biosystems (Assay-by-Design). The clock genes analyzed were Cryptochrome 1 (Cry1), Aryl hydrocarbon receptor nuclear translocator-like (Arntl, also called Bmal1) and Period homolog 2 (Per2). For a negative control, the same setup was used without reverse transcriptase. All samples were determined in duplicate; in brief, clock genes mRNA and 18S RNA were amplified in separated wells at 951C for 10 min, followed by repeating cycles comprised of 951C for 30 s and 601C for 60 s for annealing and extension steps.
Relative quantities of transcript were calculated using the 2
ÀDDCt formula according to the provider's manual, where C t is defined as the cycle number at which fluorescence is statistically significantly above background; DC t is the difference between C t of the clock genes and C t of 18S; and DDC t is the difference between DC t of unknown sample and DC t of the calibrator/control sample. 18 The results are expressed in arbitrary units and referred to the mean mRNA level from the control group. Amplification of specific transcripts was further confirmed by agarose gel electrophoresis. 
Statistical analysis
Results
General characteristics of the population Table 1 contains general characteristics of the men studied. BMI was always higher than 40 kg/m 2 in these patients, indicating morbid obesity. As expected, the HOMA index was over normal values (3.8) . 17 In the light of this result, this population can be defined as insulin resistant. According to the International Diabetes Federation (IDF), subjects met the criteria to be defined as metabolic syndrome patients. As it is observed in Table 2 , average values of waist, tryglicerides, glucose and systolic pressure exceeded the cutoff points proposed by the IDF. 19 Depot-specific clock genes expression Paired AT biopsies from the subcutaneous and visceral depots were obtained from each patient. When relative expression of the three clock genes was studied, we found Clock genes and metabolic syndrome in humans P Gómez-Abellán et al significant differences (Po0.001; Figure 1 ). Concretely, hBmal1 expression was significantly lower than hPer2 and hCry1 (Po0.001), whereas there were no significant differences between the latter two. This situation was similar in visceral and in subcutaneous AT (Figures 1a and b) . When gene expression levels were compared between both depots, no significant differences were obtained (P40.05 in all cases; Figures 2a-c) .
Pearson's correlation coefficients between the clock genes studied are shown in Figure 3 . In the subcutaneous depot, all genes were significant and positively correlated to each other, whereas in the omental depot no association was found between hBmal1 and hPer2 (Figures 3a and b) .
All these results confirm the idea that the expressions of the different clock genes are highly correlated to each other.
Relations between metabolic syndrome parameters and clock genes expression
Associations between clock genes expression and several parameters of the metabolic syndrome were studied by Person's correlation analysis.
In the omental depot, hPer2 expression levels were negatively correlated with waist circumference (r ¼ À0.928, P ¼ 0.01; Figure 4 ), a marker of central obesity and a key predictor of metabolic syndrome.
Possible correlations between clock genes expression and different cardiovascular risk factors were also analyzed. Our data showed that the three genes studied were significantly and negatively associated to total cholesterol (hBmal1: r ¼ À0.789, P ¼ 0.020; hPer2: r ¼ À0.891, P ¼ 0.003; hCry1: r ¼ À0.890, P ¼ 0.003) and LDL cholesterol (hBmal1: r ¼ À0.853, P ¼ 0.007; hPer2: r ¼ À0.875, P ¼ 0.004; hCry1: r ¼ À0.908, P ¼ 0.002). These significant associations were observed exclusively in the subcutaneous AT. Clock genes and metabolic syndrome in humans P Gómez-Abellán et al Clock genes and metabolic syndrome in humans P Gómez-Abellán et al
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Discussion
This study provides the first evidence of expression of the core molecular clock components Per2, Bmal1, Cry1 in human AT. The first direct evidence that adipocytes posses the molecular machinery for a biological clock came from analysis in mice. 20 In 2005, Ando et al. 14 demonstrated that the intracellular clock gene system acts in visceral AT and can be influenced by obesity or type 2 diabetes. Recently, it has been documented that these clock genes are expressed in AT from big mammals, specifically horse. 21 However, no studies have been previously performed in human AT, and neither compared two different AT regions, such as subcutaneous and visceral fat, with different characteristics and pathophysiological implications. In the present study Per2, Bmal1 and Cry1 were selected for the analysis, since they are key components of the circadian clock, and have been shown to exhibit robust oscillations in the peripheral tissues of other species. 9, 21 Our data show that hPer2 and hCry1 are expressed 10-20 times more than mBmal1 in both visceral and subcutaneous ATs, being the relative expression patterns of the three clock genes similar between both AT locations. The differences in the relative gene expression suggest that, at the time of surgery (1100 hour), the expression of hBmal1 occurred in anti-phase to those of hPer2 and hCry1. These data are in accordance with previous studies performed in mice, which showed that hBmal1 has its nadir (lowest levels) Zeitgeber time 12. 22 However, in the present work it was not possible to study the oscillation patterns of these genes expression in the human AT. To obtain AT biopsies requires rather invasive techniques that may injure the patient. Moreover, for visceral AT it is necessary to submit the patient to a surgical process, which makes it impossible to sample AT from the same patient at different hours of the day.
Results in other species have demonstrated that peripheral tissues share a similar pattern of clock gene expression, exemplified by the anti-phase oscillation of Per2 and Bmal1 mRNAs exhibited in heart, lung, liver, eye, kidney and pancreas. [23] [24] [25] With respect to AT, studies performed in mice and horses also showed an inverse expression profile between Bmal1 and Per2 and Cry1. 14, 21, 22 Parallel, human studies confined to less invasive measurements in peripheral blood, oral mucosa and skin showed similar temporal clock genes expression.
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When Pearson's correlation coefficients between the three clock genes studied were calculated in subcutaneous AT, all genes were significant and positively correlated to each other. It is known that the CLOCK:BMAL1 heterodimer activates the transcription of period and cryptocrome genes, and it is only when PER and CRY proteins reach a critical concentration that they attenuate the CLOCK:BMAL1 transactivation, thereby generating a circadian oscillation in their own transcription. 9, 10 Of special interest in this study is the lack of association between Bmal1 and Per2 in the visceral AT, which was significant and positively correlated in the subcutaneous fat obtained from the same subjects and at the same time. These data suggest that there is a phase shift in the gene expression of both AT locations at the time of sampling. However, this lack of correlation was observed only between Bmal1 and Per2, but not between Bmal1 and Cry1. These results as a whole could indicate that in the visceral AT, some disturbances occur in BMAL1 function and in its effects on PER2 that could be related to the pathophysiology of this adipose region and its implications on the metabolic syndrome.
When a paired t-test comparing the gene expression from subcutaneous and visceral depots was performed, no significant differences were found between both regions, although there was a tendency to a lower expression of the three genes in visceral fat. The lack of statistical significance could be a consequence of the low number of subjects included in the study (n ¼ 8), and further studies are necessary to confirm these data. Waist circumference has been described as the best anthropometric index for estimation of visceral fat content. 29, 30 Indeed, in the clinical practice, metabolic syndrome is diagnosed in men with a waist perimeter higher than 94 cm plus any two of the following parameters: high serum triglycerides, low HDL cholesterol concentrations, high serum glucose and high blood pressure. 19 Taking this definition into account, the patients studied in the present work suffered from metabolic syndrome. The current study clearly demonstrates that the expression of hPer2 in visceral AT (not in the subcutaneous) is negatively correlated to waist perimeter in morbid obese subjects. The importance of Per2 as a crucial regulator of the mammalian Clock genes and metabolic syndrome in humans P Gómez-Abellán et al circadian clock has been recently demonstrated. 31 This gene was literally cloned as a secondary mammalian period gene, after Per1. 32, 33 However, it has been recently reported that
Per1 is not absolutely required for the generation and maintenance of circadian rhythms, 34, 35 while Per2 shows a robust cell-autonomous circadian fluctuation in its transcription, being a core component for rhythm generation. Perhaps the lack of correlation between Bmal1 and Per2 found in the visceral fat depot from the patients studied is related to the negative association of Per2 with abdominal fat accumulation. Many studies have demonstrated an interaction between BMAL1 and PER proteins. Overexpression of BMAL1 in murine 3T3-L1 adipocytes not only induced the expression of several lipid metabolism-related factors, promoting lipogenesis, but also luciferase activity driven by the promoter of Per2, which is a known target gene of BMAL1, was increased. 20, 31 A failure in the relationship between both clock genes, highly implicated in adipogenesis, could be influencing body fat distribution and the physiological disturbances related to abdominal fat accumulation. In the present moment, an increasing number of evidences point out that the disruption of the circadian system may have profound clinical relevance in some pathologies, including cancer disease and metabolic syndrome. For example, mPer2 expression has been recently related with tumor suppression because overexpression of Per2 in some mouse carcinoma cell lines results in reduced cellular proliferation and rapid apoptosis. 36 Moreover, in humans, long-term shift work and frequent traveling between time zones have been associated with marked disturbances of the internal daily metabolic cycles and neurological, gastrointestinal and cardiovascular diseases. 37 Indeed, in the present work, clock genes expression in the subcutaneous fat was associated to total and LDL cholesterol, suggesting that in these morbid obese patients, the different clock genes are related to the disturbances associated to obesity. Shimba et al. 20 recently showed that Bmal1 overexpression induces the transcription of lipogenic enzymes in 3T3-L1 adipocytes and the circadian expression of sterol regulatory element binding protein, which is highly implicated in cholesterol metabolism.
In summary, we have demonstrated, for the first time in humans, that clock genes are expressed in both subcutaneous and visceral fat depots. The associations with abdominal fat content and with certain cardiovascular risk factors may be an indicator of the potential role of these clock genes in the metabolic syndrome disturbances.
Since these results raise more questions than answers, they encourage further investigations on peripheral clocks and their plausible role in human AT pathophysiology.
